CCT

Lung cancer is one of the most common cancers in the United States, yet patients with advanced non-small cell lung cancer (NSCLC) have limited effective treatment options, often offering only modest improvements in survival. The landscape for NSCLC treatment is changing rapidly, however, and many new targeted and immunotherapy agents are being studied in NSCLC clinical trials. Low participation in…